Advanced search
Publication Cover
The American Statistician Volume 73, 2019 - Issue sup1: Statistical Inference in the 21st Century: A World Beyond p < 0.05
Submit an article Journal homepage
3,956
Views
14
CrossRef citations to date
0
Altmetric
Adopting More Holistic Approaches

Trial Size for Near-Optimal Choice Between Surveillance and Aggressive Treatment: Reconsidering MSLT-II

Charles F. ManskiDepartment of Economics and Institute for Policy Research, Northwestern University, Evanston, IL; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7260-7686
ORCID Icon &
Aleksey TetenovDepartment of Economics, University of Bristol, Bristol, UK
Pages 305-311 | Received 04 Sep 2018, Accepted 27 Oct 2018, Published online: 20 Mar 2019

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Peter Bacchetti. (2019) The Other Arbitrary Cutoff. The American Statistician 73:4, pages 413-414.
Read now
Ronald L. Wasserstein, Allen L. Schirm & Nicole A. Lazar. (2019) Moving to a World Beyond “p < 0.05”. The American Statistician 73:sup1, pages 1-19.
Read now

Articles from other publishers (12)

Charles F. Manski. (2024) Toward Patient-Centered Drug Approval for Treatment of Rare Diseases. Value in Health.
Crossref
Jeff Dominitz & Charles F. Manski. (2024) Comprehensive Oos Evaluation of Predictive Algorithms with Statistical Decision Theory. SSRN Electronic Journal.
Crossref
Timothy B. Armstrong & Shu Shen. (2023) Inference on optimal treatment assignments. The Japanese Economic Review 74:4, pages 471-500.
Crossref
Eduardo M. Azevedo, David Mao, José Luis Montiel Olea & Amilcar Velez. (2023) The A/B testing problem with Gaussian priors. Journal of Economic Theory 210, pages 105646.
Crossref
Charles F. Manski. (2023) Probabilistic prediction for binary treatment choice: With focus on personalized medicine. Journal of Econometrics 234:2, pages 647-663.
Crossref
Sheyu Li, Valentyn LitvinCharles F. Manski. (2023) Partial Identification of Personalized Treatment Response with Trial-reported Analyses of Binary Subgroups. Epidemiology 34:3, pages 319-324.
Crossref
Alain Bultez, Christian Derbaix & Jean-Luc Herrmann. (2021) Statistically significant? Let us recognize that estimates of tested effects are uncertain. Recherche et Applications en Marketing (English Edition) 37:1, pages 82-105.
Crossref
Alain Bultez, Christian Derbaix & Jean-Luc Herrmann. (2021) « Statistiquement significatif » ? Respectons l’incertitude de l’effet testé. Recherche et Applications en Marketing (French Edition) 37:1, pages 87-112.
Crossref
Charles F. Manski & Aleksey Tetenov. (2021) Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs. Value in Health 24:5, pages 641-647.
Crossref
Valentyn LitvinCharles F. Manski. (2021) Evaluating the maximum regret of statistical treatment rules with sample data on treatment response. The Stata Journal: Promoting communications on statistics and Stata 21:1, pages 97-122.
Crossref
Charles F. Manski. (2021) Econometrics for Decision Making: Building Foundations Sketched by Haavelmo and Wald. Econometrica 89:6, pages 2827-2853.
Crossref
Charles F. Manski. (2021) Probabilistic Prediction for Binary Treatment Choice: With Focus on Personalized Medicine. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.